524 related articles for article (PubMed ID: 15234029)
1. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
3. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation.
Castadot P; Geets X; Lee JA; Christian N; Grégoire V
Radiother Oncol; 2010 May; 95(2):209-17. PubMed ID: 20385413
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
5. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results.
Capelle L; Mackenzie M; Field C; Parliament M; Ghosh S; Scrimger R
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):208-15. PubMed ID: 22196796
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
[TBL] [Abstract][Full Text] [Related]
8. Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans.
Siebers JV; Keall PJ; Wu Q; Williamson JF; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):422-33. PubMed ID: 16168835
[TBL] [Abstract][Full Text] [Related]
9. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
10. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
12. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
[TBL] [Abstract][Full Text] [Related]
13. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning.
Dirix P; Vandecaveye V; De Keyzer F; Op de Beeck K; Poorten VV; Delaere P; Verbeken E; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):761-6. PubMed ID: 19540069
[TBL] [Abstract][Full Text] [Related]
16. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
17. Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies.
Bieri S; Bentzen SM; Huguenin P; Allal AS; Cozzi L; Landmann C; Monney M; Bernier J
Strahlenther Onkol; 2003 Jun; 179(6):390-5. PubMed ID: 12789465
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Newbold KL; Partridge M; Cook G; Sharma B; Rhys-Evans P; Harrington KJ; Nutting CM
Acta Oncol; 2008; 47(7):1229-36. PubMed ID: 18661420
[TBL] [Abstract][Full Text] [Related]
19. A population-based atlas and clinical target volume for the head-and-neck lymph nodes.
Poon I; Fischbein N; Lee N; Akazawa P; Xia P; Quivey J; Phillips T
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1301-11. PubMed ID: 15275713
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
Chufal KS; Rastogi M; Srivastava M; Pant MC; Bhatt ML; Srivastava K
Jpn J Clin Oncol; 2006 Sep; 36(9):537-46. PubMed ID: 16905755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
